![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 53, 38097-38106, December 31, 1999
, and
From the Department of Pediatrics and the Metabolic Research Unit,
University of California, San Francisco,
San Francisco, California 94143-0978
The CYP21 gene, which encodes
P450c21, the adrenal steroid 21-hydroxylase needed for glucocorticoid
synthesis, lies in the major histocompatibility locus only 2.3 kilobase
pairs (kb) downstream from the C4 gene. A 300-base pair
(bp) proximal promoter and two upstream regions within C4
are needed for expression of mouse CYP21; the human gene
also has a proximal promoter, but upstream elements have not been
studied. To search for upstream regulatory elements in human
CYP21B, we examined up to 9 kb of 5'-flanking DNA by
transient transfection into human adrenal NCI-H295A cells. The 300-bp
proximal promoter had substantial activity, but constructs retaining
the DNA between
4.6 and
5.6 kb had increased activity, indicating
the presence of distal elements. This region does not correspond to the
mouse upstream regions, lying further upstream within intron 35 of
C4B, which encompasses the previously described "Z
promoter." DNase I footprinting located two elements, F1 and F2,
lying
186 to
195 bp and
142 to
151 bp upstream from the Z cap
site (
4862 to
4871 and
4818 to
4827 bp upstream of the CYP21B cap site). Each element formed a specific
DNA-protein complex and conferred orientation-independent expression to
a heterologous promoter. Mutations abolished formation of the
DNA-protein complexes but only partially decreased expression. We
identified a third site, F3, lying at
33 to
42 bp from Z. Competitive gel mobility supershift assays and co-transfection studies
with SF-1 produced in vitro indicate F2 and F3 bind SF-1;
BLAST searches and Southwestern blotting suggest that NF-W2 may bind
F1. These results indicate that the Z promoter is a component of the
CYP21 promoter needed to drive its adrenal-specific
expression and that CYP21 transcription elements within
C4 have kept these two genes linked during evolution.
Supported in part by the International Scholars program of the
Lawson Wilkins Pediatric Endocrine Society.
§
To whom all correspondence should be addressed: Dept. of
Pediatrics, Bldg. MR-IV, Rm. 209, University of California, San
Francisco, San Francisco, CA 94143-0978.
This article has been cited by other articles:
![]() |
M. Doghman, T. Karpova, G. A. Rodrigues, M. Arhatte, J. De Moura, L. R. Cavalli, V. Virolle, P. Barbry, G. P. Zambetti, B. C. Figueiredo, et al. Increased Steroidogenic Factor-1 Dosage Triggers Adrenocortical Cell Proliferation and Cancer Mol. Endocrinol., December 1, 2007; 21(12): 2968 - 2987. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Araujo, B. B. Mendonca, A. S. Barbosa, C. J. Lin, J. A. M. Marcondes, A. E. C. Billerbeck, and T. A. S. S. Bachega Microconversion between CYP21A2 and CYP21A1P Promoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4028 - 4034. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Winnay and G. D. Hammer Adrenocorticotropic Hormone-Mediated Signaling Cascades Coordinate a Cyclic Pattern of Steroidogenic Factor 1-Dependent Transcriptional Activation Mol. Endocrinol., January 1, 2006; 20(1): 147 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Huang, A. Dardis, and W. L. Miller Regulation of Cytochrome b5 Gene Transcription by Sp3, GATA-6, and Steroidogenic Factor 1 in Human Adrenal NCI-H295A Cells Mol. Endocrinol., August 1, 2005; 19(8): 2020 - 2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Pandey and W. L. Miller Regulation of 17,20 Lyase Activity by Cytochrome b5 and by Serine Phosphorylation of P450c17 J. Biol. Chem., April 8, 2005; 280(14): 13265 - 13271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Payne and D. B. Hales Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones Endocr. Rev., December 1, 2004; 25(6): 947 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Fluck and W. L. Miller GATA-4 and GATA-6 Modulate Tissue-Specific Transcription of the Human Gene for P450c17 by Direct Interaction with Sp1 Mol. Endocrinol., May 1, 2004; 18(5): 1144 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Xie, L. Rowen, B. Aguado, M. E. Ahearn, A. Madan, S. Qin, R. D. Campbell, and L. Hood Analysis of the Gene-Dense Major Histocompatibility Complex Class III Region and Its Comparison to Mouse Genome Res., December 1, 2003; 13(12): 2621 - 2636. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Fluck, J. W. M. Martens, F. A. Conte, and W. L. Miller Clinical, Genetic, and Functional Characterization of Adrenocorticotropin Receptor Mutations Using a Novel Receptor Assay J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4318 - 4323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Baumgartner-Parzer, E. Schulze, W. Waldhausl, S. Pauschenwein, S. Rondot, P. Nowotny, K. Meyer, H. Frisch, F. Waldhauser, and H. Vierhapper Mutational Spectrum of the Steroid 21-Hydroxylase Gene in Austria: Identification of a Novel Missense Mutation J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4771 - 4775. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lin, J. W. M. Martens, and W. L. Miller NF-1C, Sp1, and Sp3 Are Essential for Transcription of the Human Gene for P450c17 (Steroid 17{alpha}-hydroxylase/17,20 lyase) in Human Adrenal NCI-H295A Cells Mol. Endocrinol., August 1, 2001; 15(8): 1277 - 1293. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |